BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma.
Raghunandan S, Pauly M, Blum WG, Qayed M, Dhodapkar MV, Elkhalifa M, Watkins B, Schoettler M, Horwitz E, Parikh S, Chandrakasan S, Leung K, Bryson E, Deeb L, Kaufman JL, Worthington-White D, Alazraki A, Schecter JM, Madduri D, Jackson CC, Zudaire E, Taraseviciute-Morris A, Babich A, Nesheiwat T, Vogel M, Lendvai N, Pacaud L, Williams KM.
Raghunandan S, et al. Among authors: dhodapkar mv.
J Immunother Cancer. 2023 May;11(5):e006684. doi: 10.1136/jitc-2023-006684.
J Immunother Cancer. 2023.
PMID: 37137553
Free PMC article.